AbCellera Biologics Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of ABCL for the last quarter is 9.18 M USD, and it's 39.10% higher compared to the previous quarter. The net income of Q4 23 is -47.15 M USD.